News More than 1 million contraception appointments delivered by pharmacies in six months The 1,007,415 pharmacy contraception service consultations included 375,040 emergency hormonal contraception consultations.…Published: 28 July 2026
News Members of the public recruited as Pharmacy First ambassadors Under this NHS Cornwall and Isles of Scilly and NHS Devon-led initiative, ambassadors will help spread awareness of Pharmacy First services by sharing their own experiences.…Published: 27 July 2026
Opinion Post-finasteride syndrome: pharmacists must lead the conversation on patient safety We would not accept a tooth-whitening procedure that carried a risk of suicide, persistent sexual dysfunction and irreversible neurological harm. Why is it being accepted with finasteride?…Published: 27 July 2026
News Health news round-up: coffee, ADHD prescribing, and GLP-1s and hair loss The Pharmaceutical Journal’s weekly summary of the important developments in pharmacy and health news you may have missed.…Published: 24 July 2026
News NHS England could mobilise pharmacists in mass casualty incidents under new framework According to its framework on the management of mass casualty incidents, NHS England said that community pharmacies would offer support to people who go directly to pharmacies with minor injuries or health concerns following such an event.…Published: 24 July 2026
News Negotiator to challenge prime minister on business rates relief Community Pharmacy England said it had made a “clear case” for business rates relief during funding negotiations and will put these arguments to Andy Burnham's government.…Published: 23 July 2026
Feature Everything you need to know about clinical trial legislation changes Clinical trial legislation has been overhauled to speed up set-up times and include a broader range of healthcare professionals, but what do the reforms mean for patients and pharmacists?…Published: 23 July 2026
News Novo Nordisk sues Eli Lilly over ‘misleading’ GLP-1 advertising Novo Nordisk claims that Lilly’s advertising campaigns intentionally used outdated studies to offer “proof of broad, product-level superiority” of its Zepbound and Mounjaro products over Novo Nordisk’s Wegovy and Ozempic products.…Published: 22 July 2026
News Community pharmacists most confident in minor ailment prescribing, survey suggests A National Pharmacy Association survey found that nearly three-quarters of pharmacists felt that using prescribing to manage minor acute illnesses was the area that added most value.…Published: 21 July 2026
Opinion PJ view: Patients deserve a regulatory system built to keep them safe as oral semaglutide launches Regulators have taken welcome steps to tackle counterfeit weight-loss medicines, but patients cannot be left to police this market alone.…Published: 21 July 2026
